Dermapharm Holding SE

BATS-CHIXE:DMPD Stock Report

Market Cap: €2.0b

Dermapharm Holding Future Growth

Future criteria checks 1/6

Dermapharm Holding is forecast to grow earnings and revenue by 7.4% and 2% per annum respectively while EPS is expected to grow by 6.8% per annum.

Key information

7.4%

Earnings growth rate

6.8%

EPS growth rate

Pharmaceuticals earnings growth19.7%
Revenue growth rate2.0%
Future return on equityn/a
Analyst coverage

Low

Last updated19 Oct 2023

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

BATS-CHIXE:DMPD - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20251,1781481622155
12/31/20241,1271311541985
12/31/20231,1101251251755
6/30/20231,151123267304N/A
3/31/20231,128146287323N/A
12/31/20221,041134250289N/A
9/30/20221,024176222269N/A
6/30/20221,004185191249N/A
3/31/2022980211190252N/A
12/31/2021960210189250N/A
9/30/2021902162153209N/A
6/30/2021858123115164N/A
3/31/20218289596139N/A
12/31/20208088690131N/A
9/30/20207758060104N/A
6/30/2020760775897N/A
3/31/20207438569114N/A
12/31/20197147754101N/A
9/30/2019674735190N/A
6/30/20196397770109N/A
3/31/20196117384115N/A
12/31/201858475133159N/A
9/30/201855875143165N/A
6/30/20185257662137N/A
3/31/20184987945120N/A
12/31/2017480781287N/A
9/30/201748684884N/A
12/31/201645577N/A77N/A
12/31/201539613N/A40N/A
12/31/20144020N/A54N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: DMPD's forecast earnings growth (7.4% per year) is above the savings rate (1.5%).

Earnings vs Market: DMPD's earnings (7.4% per year) are forecast to grow slower than the UK market (10.3% per year).

High Growth Earnings: DMPD's earnings are forecast to grow, but not significantly.

Revenue vs Market: DMPD's revenue (2% per year) is forecast to grow slower than the UK market (4% per year).

High Growth Revenue: DMPD's revenue (2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if DMPD's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y